Jove
Visualize
Contact Us

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Considerations for creating effective academic-industrial partnerships.

Nature aging·2025
Same author

Interventions for cognitive frailty: developing a Delphi consensus with multidisciplinary and multisectoral experts.

Frontiers in aging neuroscience·2025
Same author

An observational cohort study of longitudinal impacts on frailty and well-being of COVID-19 lockdowns in older adults in England and Spain.

Health & social care in the community·2022
Same author

Sources of Cognitive Conflict and Their Relevance to Theory-of-Mind Proficiency in Healthy Aging: A Preregistered Study.

Psychological science·2021
Same author

Specific Autobiographical Recall Mediates Impact of Cognition and Depression on Independence Function and Well-Being in Older Adults.

Frontiers in psychology·2021
Same author

Developing and validating the Community-Oriented Frailty Index (COM-FI).

Archives of gerontology and geriatrics·2020
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 19, 2026

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents
10:16

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents

Published on: August 16, 2024

Point-of-care testing and molecular diagnostics: miniaturization required.

Frederick L Kiechle1, Carol A Holland

  • 1Department of Pathology, Pathology Consultants of South Broward, LLP, Memorial Regional Hospital, Hollywood, FL 33021, USA. fkiechle@mhs.net

Clinics in Laboratory Medicine
|October 21, 2009
PubMed
Summary
This summary is machine-generated.

Developing a point-of-care molecular diagnostic device is crucial for rapid infectious agent detection and personalized medicine. This portable, low-cost, all-in-one assay system will revolutionize global molecular diagnostics.

More Related Videos

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

Microfluidic Chip Fabrication and Method to Detect Influenza
09:43

Microfluidic Chip Fabrication and Method to Detect Influenza

Published on: March 26, 2013

Related Experiment Videos

Last Updated: Jun 19, 2026

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents
10:16

Point-of-care CRISPR-based Diagnostics with Premixed and Freeze-dried Reagents

Published on: August 16, 2024

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

Microfluidic Chip Fabrication and Method to Detect Influenza
09:43

Microfluidic Chip Fabrication and Method to Detect Influenza

Published on: March 26, 2013

Area of Science:

  • Biotechnology
  • Medical Diagnostics
  • Microfluidics

Background:

  • Rapid turnaround time for molecular diagnostic tests is critical for timely clinical decision-making.
  • Current molecular diagnostic methods often require complex laboratory infrastructure and trained personnel.
  • Point-of-care (POC) testing offers a potential solution for decentralized and rapid molecular diagnostics.

Purpose of the Study:

  • To outline the requirements and technological advancements needed for an ideal point-of-care molecular diagnostic device.
  • To highlight the potential impact of such a device on infectious disease detection, pharmacogenomics, and minimal residual disease monitoring.
  • To project the timeline for the availability of integrated POC molecular diagnostic systems.

Main Methods:

  • Miniaturization of nucleic acid extraction, amplification, and detection technologies.
  • Integration of microfluidics, microarrays, and capillary systems for efficient reagent handling and thermal management.
  • Development of a disposable, all-in-one unit for simplified assay performance.

Main Results:

  • The proposed device aims for low cost per test and requires no interpretation of results.
  • Miniaturization and microfluidic integration are key to reducing reagent volumes and improving heat transfer.
  • The development focuses on a portable, user-friendly system for broad accessibility.

Conclusions:

  • An integrated point-of-care molecular diagnostic device is feasible within 3-5 years.
  • Such a device will significantly enhance the global accessibility and application of molecular diagnostics.
  • This technology has the potential to revolutionize patient care through rapid, decentralized molecular testing.